Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Evaluation and Program Planning|February 26, 2022
Integrating user experience evaluation in the development of a web-based Community Engagement ToolkitAsih Asikin-Garmager, Patrick Dowd, Salim George, et al.
Health Services Research|November 22, 2022
A qualitative study of clinicians' perspectives on a law that allows for a 12-month supply of short-acting contraceptives in Massachusetts: Barriers and facilitators to implementationNeena T Qasba, Patrick Dowd, Elyse Bianchet, et al.
Viruses|September 28, 2024
Syringe Access, Syringe Sharing, and Perceptions of HCV: A Qualitative Study Exploring the HCV Risk Environment in Rural Northern New England, United StatesEric Romo, Elyse Bianchet, Patrick Dowd, et al.
Nature|April 23, 2004
The ubiquitin ligase COP1 is a critical negative regulator of p53David Dornan, Ingrid Wertz, Harumi Shimizu, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|March 18, 2022
"I've been to more of my friends' funerals than I've been to my friends' weddings": Witnessing and responding to overdose in rural Northern New EnglandKerry Nolte, Eric Romo, Thomas J Stopka, et al.
Viruses|September 28, 2024
More than Just Buying a Van: Lessons Learned from a Mobile Telehealth HCV Testing and Treatment StudyElyse Bianchet, David de Gijsel, Lizbeth M Del Toro-Mejias, et al.
Cancer Research|October 20, 2004
COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomasDavid Dornan, Sheila Bheddah, Kim Newton, et al.
International Immunology|July 20, 2006
Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemiaAndrew G Polson, Bing Zheng, Kristi Elkins, et al.
JAMA Network Open|January 26, 2026
Mobile Telemedicine for Treating Chronic Hepatitis C Among Rural People Who Inject Drugs: A Randomized Clinical TrialPeter D Friedmann, Donna Wilson, David de Gijsel, et al.
Cancer Research|November 4, 2005
Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancersDaniel Gray, Adrian M Jubb, Deborah Hogue, et al.
Pageof 2